Vimarsana
Biggest News Aggregation in the World

Development For Sanofi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development For Sanofi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development For Sanofi Today - Breaking & Trending Today

Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D - Vimarsana News

Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) (the Company) today announced the appointment of John Reed, M.D., Ph.D., to the Company’s Executive Committee as Executive Vice President of Pharmaceuticals, R&D. Dr. Reed previously served as Executive Vice President, Global Head of Research and De...

J&J appoints new Executive Vice President, Pharmaceuticals, R&D - Vimarsana News

J&J appoints new Executive Vice President, Pharmaceuticals, R&D

An executive from Sanofi has been appointed as Johnson & Johnson’s new Executive Vice President of Pharmaceuticals, R&D.

Opko Health (OPK) Q2 2022 Earnings Call Transcript - Vimarsana News

Opko Health (OPK) Q2 2022 Earnings Call Transcript

OPK earnings call for the period ending June 30, 2022.

Source: fool.com
OPKO Health, Inc.'s (OPK) CEO Phillip Frost on Q2 2022 Results - Earnings Call Transcript - Vimarsana News

OPKO Health, Inc.'s (OPK) CEO Phillip Frost on Q2 2022 Results - Earnings Call Transcript

OPKO Health, Inc. (NASDAQ:NASDAQ:OPK) Q2 2022 Earnings Conference Call August 04, 2022, 04:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and...

OPKO Health, Inc. (OPK) CEO Phillip Frost on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

OPKO Health, Inc. (OPK) CEO Phillip Frost on Q1 2022 Results - Earnings Call Transcript

OPKO Health, Inc. (NASDAQ:NASDAQ:OPK) Q1 2022 Earnings Conference Call May 09, 2022, 16:30 ET Company Participants Yvonne Briggs - LHA Phillip Frost - Chairman & CEO Adam Logal - SVP,...